Stay updated with breaking news from Nathaniel Erdmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.
This Medical News story discusses the relationship between the COVID-19 pandemic and recent increases in other respiratory diseases.
Scientists work toward an elusive dream: a simple pill to treat Covid-19 Adobe The world has vaccines that can prevent most cases of Covid-19. It even has drugs that can help with the most serious symptoms of the disease. Now what it needs is a Tamiflu for SARS-CoV-2. It would be a pill, exquisitely calibrated to target SARS-CoV-2, with tolerable side effects and a low price tag. And it would work just as well as those antibody treatments that require an hourlong intravenous infusion, but it would come in a handy packet patients could take home. “We’re looking for something I could give e...